Clinical Trial Research Of Vaccines
- All
- News
-
Clinical Trials Of New TB Vaccine To Start Soon: Ex Scientific Body Chief
Clinical trials of a new BCG vaccine for tuberculosis will soon start in India, former director-general of the Council of Scientific & Industrial Research (CSIR) Dr Shekhar Mande said on Friday.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
-
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
-
China's Experimental COVID-19 Vaccine Appears Safe In Early Trials: Study
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.
-
India Launches Program To Strengthen Clinical Trial Research Of Vaccines In Neighbouring Nations
Amid the COVID-19 pandemic, India has started a "science diplomacy" initiative by launching a programme to strengthen the capacity of clinical trial research of vaccines in neighbouring countries, the Department of Biotechnology said today.
-
Over 1,100 People For Clinical Trials Of India's First Covid Vaccine
More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...
-
Soon, a Pain-Free Patch May Replace Flu Shots
A group of researchers from the Georgia Institute of Technology and Emory University, are now working on creating a pain-less patch that can help people self-administer the vaccine with the press of a thumb.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
US Health Researchers Test Zika Vaccine As Funds Run Low
US government researchers said on Wednesday they have begun their first clinical trial of a Zika vaccine while the Obama administration told lawmakers funds to fight the virus would run out in the coming weeks due to congressional inaction.
-
Clinical Trials Of New TB Vaccine To Start Soon: Ex Scientific Body Chief
Clinical trials of a new BCG vaccine for tuberculosis will soon start in India, former director-general of the Council of Scientific & Industrial Research (CSIR) Dr Shekhar Mande said on Friday.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Recruitment Of Volunteers For Trial Of Covovax Vaccine On Children Begins
Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Oxford Vaccine "Could Be Realistic Solution" To Covid: Medical Body ICMR
The Pune-based Serum Institute of India (SII) and Indian Council of Medical Research (ICMR) on Thursday announced the completion of enrolment of phase-3 clinical trials for potential COVID-19 vaccine Covishield in India.
-
Phase 3 Trials Of Covaxin Begin, AMU Vice Chancellor Is First Volunteer
The third phase of clinical trials for Covaxin, the coronavirus vaccine being developed by pharmaceutical firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has started. The Vice Chancellor of Aligarh Muslim University (AMU) registered as the first volunteer for the trails which will take place at the universit...
-
Covaxin, Bharat Biotech's Coronavirus Vaccine, Cleared For Phase 3 Trials
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has been cleared for the third phase of clinical trials.
-
Britain's Spies Defending COVID-19 Vaccine Work, MI5 Chief Says
British spies are trying to defend COVID-19 vaccine work against hostile powers that seek to either steal or sabotage research data in the race for the global prize of a jab that could provide immunity, the head of MI5 said on Wednesday.
-
China's Experimental COVID-19 Vaccine Appears Safe In Early Trials: Study
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.
-
India Launches Program To Strengthen Clinical Trial Research Of Vaccines In Neighbouring Nations
Amid the COVID-19 pandemic, India has started a "science diplomacy" initiative by launching a programme to strengthen the capacity of clinical trial research of vaccines in neighbouring countries, the Department of Biotechnology said today.
-
Over 1,100 People For Clinical Trials Of India's First Covid Vaccine
More than 1,100 people are expected to be enrolled in the first two phases of human clinical trials for COVAXIN - India's first COVID-19 vaccine candidate, an application by developers Bharat Biotech said Friday. Phase I clinical trials are scheduled to start next week, with July 13 set as the date for participant enrolment. Results from Phase I wi...
-
Soon, a Pain-Free Patch May Replace Flu Shots
A group of researchers from the Georgia Institute of Technology and Emory University, are now working on creating a pain-less patch that can help people self-administer the vaccine with the press of a thumb.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
US Health Researchers Test Zika Vaccine As Funds Run Low
US government researchers said on Wednesday they have begun their first clinical trial of a Zika vaccine while the Obama administration told lawmakers funds to fight the virus would run out in the coming weeks due to congressional inaction.
